Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer
โ Scribed by Yasuo Nomura; Hideya Tashiro; Katsuko Shinozuka
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 547 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Based on estrogen receptor (ER) status and menopausal status, operable breast cancer (International Union Against Cancer [UICC] Stage I, II, and III) patients were randomized for adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy, and the effects on the disease-free survival (DFS)
## Abstract Fifty-five patients with locally advanced breast cancer treated with initial endocrine therapy have been followed up for periods of between 6 and 64 months (median 17 months) with regular clinical and radiological examination. The aim of the study was to evaluate the role of mammography